A Phase I Study of Niraparib Administered Concurrently With Postoperative RT in Triple Negative Breast Cancer Patients (UNITY)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03945721 |
|
Recruitment Status :
Recruiting
First Posted : May 10, 2019
Last Update Posted : October 28, 2021
|
Sponsor:
Massachusetts General Hospital
Collaborator:
Tesaro, Inc.
Information provided by (Responsible Party):
Alice Ho, Massachusetts General Hospital
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | May 31, 2022 |
| Estimated Study Completion Date : | December 31, 2026 |